The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research M National Academies of Sciences, Engineering, HM Division, ... National Academies Press (US), 2017 | 1793 | 2017 |
Sex-dependent effects of cannabis and cannabinoids: a translational perspective ZD Cooper, RM Craft Neuropsychopharmacology 43 (1), 34-51, 2018 | 299 | 2018 |
Adverse effects of synthetic cannabinoids: management of acute toxicity and withdrawal ZD Cooper Current psychiatry reports 18, 1-10, 2016 | 242 | 2016 |
Oral cannabidiol does not alter the subjective, reinforcing or cardiovascular effects of smoked cannabis M Haney, RJ Malcolm, S Babalonis, PA Nuzzo, ZD Cooper, G Bedi, ... Neuropsychopharmacology 41 (8), 1974-1982, 2016 | 205 | 2016 |
Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts ZD Cooper, M Haney Drug and alcohol dependence 103 (3), 107-113, 2009 | 187 | 2009 |
Investigation of sex-dependent effects of cannabis in daily cannabis smokers ZD Cooper, M Haney Drug and alcohol dependence 136, 85-91, 2014 | 181 | 2014 |
Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine‐maintained intravenous heroin abusers SD Comer, MA Sullivan, SK Vosburg, J Manubay, L Amass, ZD Cooper, ... Addiction 105 (4), 709-718, 2010 | 159 | 2010 |
Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability ZD Cooper, G Bedi, D Ramesh, R Balter, SD Comer, M Haney Neuropsychopharmacology 43 (10), 2046-2055, 2018 | 153 | 2018 |
Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor ZD Cooper, M Haney Addiction biology 13 (2), 188-195, 2008 | 141 | 2008 |
Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse M Haney, ZD Cooper, G Bedi, SK Vosburg, SD Comer, RW Foltin Neuropsychopharmacology 38 (8), 1557-1565, 2013 | 135 | 2013 |
Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence ZD Cooper, M Haney International Review of Psychiatry 21 (2), 104-112, 2009 | 126 | 2009 |
Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers ZD Cooper, SD Comer, M Haney Neuropsychopharmacology 38 (10), 1984-1992, 2013 | 115 | 2013 |
Subjective, cognitive and cardiovascular dose‐effect profile of nabilone and dronabinol in marijuana smokers G Bedi, ZD Cooper, M Haney Addiction biology 18 (5), 872-881, 2013 | 108 | 2013 |
Predictors of marijuana relapse in the human laboratory: robust impact of tobacco cigarette smoking status M Haney, G Bedi, ZD Cooper, A Glass, SK Vosburg, SD Comer, RW Foltin Biological psychiatry 73 (3), 242-248, 2013 | 105 | 2013 |
Sex-dependent effects of cannabis-induced analgesia ZD Cooper, M Haney Drug and alcohol dependence 167, 112-120, 2016 | 104 | 2016 |
Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse M Haney, CL Hart, SK Vosburg, SD Comer, SC Reed, ZD Cooper, ... Psychopharmacology 211, 233-244, 2010 | 95 | 2010 |
The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid‐dependent volunteers ZD Cooper, KW Johnson, M Pavlicova, A Glass, SK Vosburg, MA Sullivan, ... Addiction biology 21 (4), 895-903, 2016 | 94 | 2016 |
Paradoxical effects of chronic morphine treatment on the temperature and pituitary‐adrenal responses to acute restraint stress: a chronic stress paradigm H Houshyar, ZD Cooper, JH Woods Journal of neuroendocrinology 13 (10), 862-874, 2001 | 86 | 2001 |
Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: a longitudinal analysis S Lake, Z Walsh, T Kerr, ZD Cooper, J Buxton, E Wood, MA Ware, ... PLoS medicine 16 (11), e1002967, 2019 | 78 | 2019 |
Novel pharmacologic approaches to treating cannabis use disorder RE Balter, ZD Cooper, M Haney Current addiction reports 1, 137-143, 2014 | 74 | 2014 |